Recurrent WHO Grade 4 Glioma Clinical Trials

5 clinical trials for Recurrent WHO Grade 4 Glioma across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Testing the Anti-cancer Drug Erdafitinib for Brain Cancers That Have Returned or Progressed Following Treatment — RECRUITING · PHASE2
• Anti-GARP Chimeric Antigen Receptor T Cell Therapy for the Treatment of Recurrent Grade III or IV Gliomas — RECRUITING · PHASE1
• Triapine in Combination With Temozolomide for the Treatment of Patients With Recurrent Glioblastoma — RECRUITING · PHASE1
• Retifanlimab with Bevacizumab and Hypofractionated Radiotherapy for the Treatment of Recurrent Glioblastoma — RECRUITING · PHASE2
• Testing the Combination of Anti-cancer Drugs Actimab-A and Cemiplimab (REGN2810) to Improve Outcomes for Patients With Recurrent Glioblastoma — NOT_YET_RECRUITING · PHASE1

Refine this search